Expression of annexin I, II and VII proteins in androgen stimulated and recurrent prostate cancer.

PURPOSE We performed a comprehensive survey of annexin I, II and VII protein expression in patient matched benign prostatic epithelium (BPE), androgen stimulated prostate cancer (AS-CaP) and recurrent prostate cancer (R-CaP). MATERIALS AND METHODS Annexin I, II and VII was immunostained in 23 matched pairs of BPE and AS-CaP specimens, and in 25 R-CaP specimens. Protein expression was assessed visually and using color digital video image analysis. RESULTS The expression levels of annexins I and II was decreased from BPE to AS-CaP in all patients examined using visual assessment (22 of 22) or digital image analysis (18 of 18 for annexin I and 22 of 22 for annexin II). Annexin I mean optical density (MOD) decreased by 69% (0.718 to 0.222, p <0.0001) and annexin II MOD decreased by 71% (0.820 to 0.238, p <0.0001). Annexin I MOD further decreased almost 50% in R-CaP compared with AS-CaP (0.117 vs 0.222, p <0.0065) and annexin II MOD further declined by 37% (AS-CaP 0.238 vs R-CaP 0.150, p <0.0001). Annexin VII MOD showed no significant change between BPE and AS-CaP (0.229 and 0.214, respectively) but it decreased 14% in R-CaP vs AS-CaP (0.184 vs 0.214, p <0.0051). CONCLUSIONS Annexins I and II expression are decreased in AS-CaP compared with BPE and a further reduction is observed with progression from AS-CaP to R-CaP. Annexin VII protein expression is decreased in R-CaP, although AS-CaP and BPE are similar. This study suggests that the dysregulations of annexin proteins I, II and VII are important events in prostate carcinogenesis and progression.

[1]  Maria D Person,et al.  Annexin II expression is reduced or lost in prostate cancer cells and its re-expression inhibits prostate cancer cell migration , 2003, Oncogene.

[2]  S. Moss,et al.  Annexins: from structure to function. , 2002, Physiological reviews.

[3]  K. Pienta,et al.  Tissue Microarray Sampling Strategy for Prostate Cancer Biomarker Analysis , 2002, The American journal of surgical pathology.

[4]  S. Clark,et al.  Loss of annexin II heavy and light chains in prostate cancer and its precursors. , 2001, Cancer research.

[5]  O. Kallioniemi,et al.  ANX7, a candidate tumor suppressor gene for prostate cancer , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[6]  P R Taylor,et al.  Loss of annexin 1 correlates with early onset of tumorigenesis in esophageal and prostate carcinoma. , 2000, Cancer research.

[7]  H. J. Harris,et al.  The Annexin Protein Lipocortin 1 Regulates the MAPK/ERK Pathway* , 1999, The Journal of Biological Chemistry.

[8]  F. Frey,et al.  Annexin I modulates cell functions by controlling intracellular calcium release , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[9]  J. Kononen,et al.  Tissue microarrays for high-throughput molecular profiling of tumor specimens , 1998, Nature Medicine.

[10]  B. Rothhut.  Participation of annexins in protein phosphorylation , 1997, Cellular and Molecular Life Sciences CMLS.

[11]  J. McKanna,et al.  Lipocortin 1 in apoptosis: Mammary regression , 1995, The Anatomical record.

[12]  J. Mohler,et al.  Nuclear morphometry in automatic biopsy and radical prostatectomy specimens of prostatic carcinoma. A comparison. , 1994, Analytical and quantitative cytology and histology.

[13]  L. Cooley,et al.  The specialized cytoskeleton of theDrosophila egg chamber , 1994 .

[14]  P. D. Smith,et al.  Structural evolution of the annexin supergene family. , 1994, Trends in genetics : TIG.

[15]  R. Flower,et al.  Lipocortin-1: cellular mechanisms and clinical relevance. , 1994, Trends in pharmacological sciences.

[16]  C. Klee,et al.  Ca2+-dependent phospholipid- (and membrane-) binding proteins. , 1988, Biochemistry.

[17]  Wei Xin,et al.  Dysregulation of the annexin family protein family is associated with prostate cancer progression. , 2003, The American journal of pathology.

[18]  D. Ornstein,et al.  Dysregulation of annexin I protein expression in high-grade prostatic intraepithelial neoplasia and prostate cancer. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[19]  Desok Kim,et al.  Immunohistochemical quantitation of androgen receptor expression using color video image analysis. , 1999, Cytometry.